| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 6e-09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.33 | 1e-08 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |